Wall Street’s Key Stock Analysts Research Report, All Buys

Wall Street’s Key Stock Analysts Research Report, All Buys

$AQST, $CHGG, $MRVL, $SPLK

These are all Buys if you can manage the risk.

Daily HeffX-LTN reviews dozens of Wall Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. These reports cover stocks to buy

Below is our list for Tuesday, 26 May, as follows:

Aquestive Therapeutics Inc. (NASDAQ:AQST) was reiterated as Buy and its price target was raised to 15 from 13 at HC Wainwright. Friday, shares were indicated up almost 9% at 6.70 after a royalty program it was involved in with Sunovion Pharmaceuticals received FDA approval.

Chegg Inc. (NYSE:CHGG) online education tools likely will be vital for students and teachers going forward. Shares most recently closed at 64.91, with a consensus price target of 44.50.

Marvell Technology Group Ltd. (NASDAQ:MRVL) was reiterated as Buy and its price target was raised to 34 from 31 at B. Riley FBR. It had a 28.83 consensus price target.

Splunk Inc. (NASDAQ:SPLK) was reiterated as Buy and its price target was raised to 190 from 160 at Stifel. Shares were indicated up over 6% at 174.00 Friday. Needham reiterated it as Buy and raised its price target to 192 from 168.

Have a healthy week, Keep the Faith!

The following two tabs change content below.

Paul Ebeling

Paul A. Ebeling, a polymath, excels, in diverse fields of knowledge Including Pattern Recognition Analysis in Equities, Commodities and Foreign Exchange, and he it the author of "The Red Roadmaster's Technical Report on the US Major Market Indices, a highly regarded, weekly financial market commentary. He is a philosopher, issuing insights on a wide range of subjects to over a million cohorts. An international audience of opinion makers, business leaders, and global organizations recognize Ebeling as an expert.